New: Manufacturing Quotes — source from manufacturers in 35 countries.Start a Project

The Operating System for Healthcare Market Access

Enter international healthcare markets with confidence.

GHMAP is the workspace where regulatory pathways, reimbursement rules, distributor and hospital relationships, and evidence-based AI analysis come together for every country you plan to enter.

Start a Project See how GHMAP works

Countries/Germany

Synced 2 min agoLow riskActive workspace

Registration Progress

Classification

Submission

Authority reviewCurrent

Approval

Launch

Reimbursement

Dossier in preparation

G-BA benefit assessment pathway

To verify

Distributors

MedBridge Distribution GmbHReviewing terms

Nordrhein Health PartnersIntroduced

Hospitals

Klinikum RheinlandEvaluation

University Hospital – LeipzigPilot interest

Timeline

BfArM pre-submission callMar 4

Technical file resubmissionMar 21

G-BA reimbursement filingApr 15

Required Documents

Technical fileReviewed

Clinical evaluation reportIn review

Free sale certificateSource required

AI Summary

High confidence

Germany registration is on track for the classification and submission stages. Reimbursement filing depends on the completed clinical evaluation report. Professional review is required before relying on this summary for decisions.

Next action

Complete clinical evaluation report

Review pending

Healthcare Manufacturers: Structured manufacturer profiles prepared for market-access review.
Healthcare Markets: Country intelligence and market-access context across active markets.
Certification Pathways: Requirements, timelines, and cost context organized for professional review.
Trust Model: Source status, review status, evidence gaps, and next actions remain visible.

Country Comparison

Which market should you prioritize?

Registration, commercial context, network coverage, risk, and readiness — grouped side by side, with a clear recommendation, for every country in a project.

Recommended market

Germany

Best Overall Market

Germany

Defined regulatory pathway, active distributor and hospital interest, and a lower risk profile.

Recommended

Fastest Entry

USA

Already approved and commercially active — no new regulatory work required.

91% ready

Highest Risk

Saudi Arabia

No distributor identified yet, and the longest estimated regulatory timeline.

High risk

Market Comparison

5 countries · 11 dimensions

Dimension	Recommended Market Germany 68% ready View market	Turkey 34% ready View market	Kenya 41% ready View market	Saudi Arabia 22% ready View market	USA 91% ready View market
Regulatory
Registration	In progress	Source required	Source required	Source required	Reviewed
Timeline (est.)	5–7 mo	6–9 mo	5–8 mo	8–12 mo	3–5 mo
Certificates	CE, ISO 13485	CE, ISO 13485	CE/FDA equiv.	SFDA MDMA	510(k)
Import route	EU free circ.	Direct import	PPB clearance	SFDA clearance	FDA cleared
Commercial
Market size	Large	Medium	Small	Medium	Large
Pricing	Regulated	Regulated	Market-set	Tender-based	Market-set
Reimbursement	G-BA filing	SGK pathway	Cash-pay	CHI review	CMS coded
Network
Distributors	2 identified	1 identified	2 identified	0 identified	Contracted
Hospitals	2 evaluating	1 evaluating	3 interested	0 engaged	6 active
Decision
Risk score	Low risk	Medium risk	Medium risk	High risk	Low risk
Readiness	68%	34%	41%	22%	91%

GHMAP Recommendation

Germany is currently the strongest non-US launch candidate.

Defined regulatory pathway
Active distributor interest
Hospital evaluation underway
Lower risk profile
Stronger launch readiness

Next action

Complete regulatory dossier review.

Professional review required

ReviewedIn progressSource requiredProfessional review required

GHMAP Market Access Journey

From market selection to scale — one controlled pathway.

GHMAP connects research, partners, pilots, regulatory work, launch, and post-market growth in one execution journey.

EZDebride — Kenya Market Entry

7 of 12 stages

Phase 1

Discover

Complete

Country Selection

Market Research

Distributor Identification

Distributor Qualification

Phase 2

Validate

In progress

Product Presentation

Sample / Pilot Evaluation

Current

Authority / Registration

Commercial Agreement

Phase 3

Launch & Scale

Upcoming

Import

Launch

Market Monitoring

Scale

Active Stage

Live

Authority / Registration

PPB Kenya

In review

OwnerRegulatory Lead

Target date28 August 2026

Documents14 of 16 complete

Source statusReviewed sources attached

Next action

Upload clinical evaluation report

Professional review

Required before submission

Execution Timeline

Done In progress Planned

Jan

Feb

Mar

Apr

May

Jun

Distributor meetings

Hospital meetings

Regulatory submission

Authority review

Approval

Commercial launch

View full market access pathway

AI Decision Workspace

Evidence-based answers, not a chat window.

Every answer is structured around sources, confidence, and what still needs professional review — never a bare conclusion.

Can EZDebride enter Kenya?

Medium confidence

Answer

Kenya Pharmacy and Poisons Board (PPB) medical device registration pathway. Class II wound-care classification likely applies, pending final classification review.

Recommendation

Proceed with PPB Class II registration. Resolve local labeling requirements and import tariff classification before submission.

Required certificates

CE Mark or FDA 510(k) equivalence file
ISO 13485 quality management certificate
Certificate of Free Sale
KEBS conformity assessment

Hospitals

Nairobi Central Medical Center
Rift Valley Regional Hospital
Coast Provincial Hospital

Distributors

East Africa Health Partners
Great Lakes Medical Distribution

Evidence & sources

Kenya PPB — Medical Device Guidelines (2024)Reviewed

KEBS Conformity Assessment RequirementsReviewed

GHMAP Distributor Network RecordsSource tracked

Local labeling requirementsSource required

Missing documents

Local labeling requirements not yet verified
Import tariff classification pending

Review status

Professional review required before reliance.

Awaiting professional review

Relationship Intelligence

See how every relationship connects to the work.

See who is connected, why the relationship matters, and what action comes next.

Selected network

Germany Market Access Network

Product1

Manufacturer1

Distributors3

Hospitals4

Doctors6

Regulatory partners2

Active projects2

Updated automatically as relationships change.

Relationship Inspector

MedBridge Distribution → EZDebride

RelationshipQualified distributor

CountryGermany

StatusReviewed

Source statusVerified

Linked projectGermany Launch

Last activity12 Jul 2026

Next action

Commercial review

CountryProductManufacturerDistributorHospitalDoctorRegulatorProject

Global Intelligence Map

Where GHMAP is operating, right now.

Five markets, one coordinated view — country stage, network readiness, and what happens next, tracked from first research to commercial launch.

Stage

Launch Ready
Authority Review
Distributor Qualification
Market Research
Pilot Evaluation

USA

Launch Ready

91% ready

Germany

Authority Review

68% ready

Turkey

Distributor Qualification

54% ready

Saudi Arabia

Market Research

32% ready

Kenya

Pilot Evaluation

62% ready

Selected Market

Kenya

Current stagePilot Evaluation

Readiness62%

DistributorMedBridge Kenya

Hospitals3 interested

Doctors12

Projects2

Source statusVerified

Professional reviewPending

Next action

Submit Clinical Evaluation Package

Live Activity

Germany Authority Review Updated
Kenya Pilot Meeting Completed
Turkey Distributor Qualified
USA Commercial Launch Approved

Verified RelationshipSelected market

What a market connection represents

Manufacturer

Distributor

Hospital

Pilot

Authority

Launch

Trusted Network

Building a trusted healthcare network.

GHMAP is developing a reviewed-access network across healthcare manufacturing, distribution, care delivery, and market-access collaboration.

Featured partner

MDM Wound Ventures

Wound care organization

Future Manufacturer

Status: Onboarding

Verified manufacturer applications are open.

Future Distributor

Status: Coming Soon

Distributor onboarding will open soon.

Future Hospital

Status: Coming Soon

Hospital and clinical partner onboarding will open soon.

Future Partner

Status: Coming Soon

Strategic healthcare partnerships will open soon.

Reviewed launch planning

Build your next market entry on one operating system.

Start with a real project — country context, source status, relationships, and next actions in one workspace.

Start a Project View Sample Brief

Professional review remains part of the workflow.